InsidersTradesSigma
SynAct Pharma AB Stock: price and directors' dealings · Finland · FIN-FSA
Follow the SynAct Pharma AB stock price and the full management transaction log of the company, a publicly traded company based in Finland. Shares trade on FI FI, under the authority of FIN-FSA. Operating in the Health Care sector, SynAct Pharma AB has recorded 0 public disclosures. Market capitalisation: €974.4m. The full history is free.
n/a
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate SynAct Pharma AB Strong Buy (bullish), based on 2 analysts. Average price target: SEK 35.00.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Declarations0 total
No declarations found
0 of 0 declarations
About SynAct Pharma AB
SynAct Pharma AB is a biopharmaceutical company focused on developing treatments for inflammatory and autoimmune diseases. It is listed on the XSTO exchange.